News

Governor Glenn Youngkin Announces Over $3.7 Million in Growth and Opportunity for Virginia Grants

Governor Glenn Youngkin announced today more than $3.7 million in Growth and Opportunity for Virginia (GO Virginia) grant awards for 11 projects designed to empower workforce development, bolster startup ecosystems and promote economic growth in the Commonwealth. These initiatives will play a pivotal role in nurturing skilled talent, fostering entrepreneurial ventures and bridging the gap between job seekers and employment opportunities.

“Today’s announcement underscores our unwavering commitment to stimulating economic growth and expanding opportunities across our Commonwealth,” said Governor Glenn Youngkin. “By investing in talent, bolstering entrepreneurial innovation and cultivating the conditions for startup success, we are actively shaping the future of our workforce and positioning Virginia as a hub for innovation and opportunity.”

The GO Virginia program advances regional economic growth and diversification by enabling cooperative projects that taps into workforce enhancement, cluster expansion, innovative business initiatives and site development.

“The GO Virginia program is at the forefront of driving regional economic growth and diversification by fostering collaborative projects that harness the potential of workforce development and startup ecosystems,” said Secretary of Commerce and Trade Caren Merrick.

In addition to the awarded GO Virginia funding, the 11 awarded projects will leverage an additional $2.5 million in local and non-state funding.

“Congratulations to the regional councils and the awardees. GO Virginia is committed to the economic success of every region of the Commonwealth, and these projects demonstrate how focused strategy and regional collaboration create an ecosystem where industries, communities and individuals can thrive,” said chair of the GO Virginia State Board Nancy Howell Agee.

Since the program’s inception in 2017, GO Virginia has funded 277 projects and awarded approximately $114 million to support regional economic development efforts.

To learn more about the GO Virginia program, visit dhcd.virginia.gov/gova.

A FULL LIST OF THE AWARDED PROJECTS CAN BE FOUND HERE.

Recent News

09/17/2026

Rivanna Announces New CMS Procedure Code for Computer-aided Neuraxial Guidance

RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the Centers for Medicare & Medicaid Services (CMS) has established ICD-10-PCS code XEZU3HC, effective for inpatient discharges beginning October 1, 2026. The code identifies computer-aided intraprocedural navigation in the spinal canal using ultrasound imaging with continuous needle tracking via a percutaneous approach during neuraxial anesthesia.

09/17/2026

From Lab to Three Continents: Agrospheres and FMC Corporation Advance Bioinsecticide Pipeline into Global Field Trials

AgroSpheres, a biotechnology company pioneering breakthroughs in sustainable crop protection and FMC Corporation (NYSE: FMC), a global leader in agricultural sciences, today announced a significant advancement in its ongoing collaboration. Two proprietary RNA-based biomolecule candidates from AgroSpheres’ pipeline are now entering global field trial development, marking the transition from discovery into real-world testing across three

09/15/2026

Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (“Jazz” or the “Company”) today announced the successful completion of its acquisition of privately-held Actio Biosciences, Inc. (“Actio”) for $820 million upfront. Actio is now a wholly-owned subsidiary of Jazz. “ABS-1230 holds the promise of being a transformative, first-in-class therapy for individuals living with KCNT1-related epilepsy,” said Renee Gala, president and